Warren Lucinda has filed 4 insider transactions across 1 company since September 2024.
Most recent transaction: a grant/award of 250000 shares of Cue Biopharma, Inc. ($CUE) on April 09, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 9, 2026 | Cue Biopharma, Inc. | $CUE | Warren Lucinda | CHIEF BUSINESS OFFICER | A | Stock Option (right to buy) | 250000 | $0.00 | 250,000.0000 | 100,869,349 | 9999.99% | 0.25% |
| Sept. 29, 2025 | Cue Biopharma, Inc. | $CUE | Warren Lucinda | CHIEF BUSINESS OFFICER | A | Stock Option (right to buy) | 125000 | $0.00 | 125,000.0000 | 56,328,348 | 9999.99% | 0.22% |
| March 21, 2025 | Cue Biopharma, Inc. | $CUE | Warren Lucinda | CHIEF BUSINESS OFFICER | A | Stock Option (right to buy) | 250000 | $0.00 | 250,000.0000 | 56,328,348 | 9999.99% | 0.44% |
| Sept. 3, 2024 | Cue Biopharma, Inc. | $CUE | Warren Lucinda | CHIEF BUSINESS OFFICER | A | Stock Option (right to buy) | 350000 | $0.00 | 350,000.0000 | 45,754,794 | 9999.99% | 0.76% |